Switch Between GLP-1 Medications with Clinical Support
What's Better Mounjaro or Wegovy: Understanding Your Switch & Save Options
When considering what's better between Mounjaro and Wegovy, many patients focus on switching to optimise their weight management approach whilst potentially reducing costs. Wegovy (semaglutide) operates as a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) functions as a dual GIP and GLP-1 receptor agonist, offering different mechanisms for appetite control and weight management. Neither medication is inherently "better"—the choice depends on your individual response, tolerance, and clinical circumstances as determined by your prescriber.
EverydayMeds stocks both options, making it simple to switch between these prescription-only medicines under proper medical supervision. Our clinical team understands the complexities of transitioning between GLP-1 medications and can guide you through dose equivalencies and timing considerations. Whether you're switching due to side effects, availability, cost considerations, or simply exploring what's better for your specific needs, we provide seamless access to both Mounjaro and Wegovy through our GPhC-registered pharmacy services.
Wegovy Pricing Advantages When Switching from Mounjaro
Patients asking what's better between Mounjaro and Wegovy often discover significant cost differences that influence their decision. Wegovy starts at £79.99 for the 0.25mg starter dose, with our Intro Duo bundle (0.25mg & 0.5mg) available for £169.99, providing your first 8 weeks of treatment. New customers can use discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25, both applied to reach our competitive final pricing. Our transparent pricing structure eliminates surprises, with maintenance doses of 2.4mg available for £209.99 per pen.
For patients considering what's better financially, Wegovy's pricing structure through EverydayMeds offers predictable costs compared to other GLP-1 medications. Our bundle options, such as the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99, provide convenient dose escalation without multiple orders. The consistency bundles, like Consistency 2.4mg (×2) for £419.99, ensure maintenance supply continuity. These pricing advantages make switching to Wegovy an attractive option for budget-conscious patients seeking effective weight management support.
Clinical Evidence Comparing Wegovy and Mounjaro Effectiveness
When evaluating what's better between Mounjaro and Wegovy, clinical trial data provides valuable context, though direct comparisons require careful interpretation due to different study designs and populations. The STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with STEP 5 showing sustained clinically studied weight loss at 2 years (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting additional health benefits beyond weight management.
Mounjaro's SURMOUNT trials showed different results using the dual GIP and GLP-1 approach, but comparing these percentages directly would be misleading due to varying trial methodologies, patient populations, and endpoints. Both medications require prescription alongside a reduced-calorie diet and increased physical activity. Your prescriber can help determine what's better for your individual circumstances based on your medical history, current medications, and treatment goals rather than relying solely on trial averages.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Understanding what's better between Mounjaro and Wegovy requires grasping their different mechanisms of action, with Wegovy functioning as a selective GLP-1 receptor agonist. This prescription-only medicine mimics glucagon-like peptide-1, a natural hormone that regulates appetite and food intake by acting on brain appetite centres. Wegovy promotes feelings of fullness after smaller meals, reduces overall appetite, and may help control food cravings that often sabotage weight management efforts. The medication works by slowing gastric emptying, which contributes to prolonged satiety and reduced caloric intake. Unlike Mounjaro's dual approach, Wegovy's focused GLP-1 action provides targeted appetite suppression with a well-established safety profile from extensive clinical experience.
Switching Process: From Assessment to Delivery
Patients wondering what's better between Mounjaro and Wegovy can explore switching through our streamlined 3-minute online clinical assessment, designed to evaluate suitability and determine appropriate starting doses. Our qualified prescribers review your medical history, current medications, and previous GLP-1 experience within 3 working days (or 24 hours with express service), ensuring safe transition protocols. Once approved, your Wegovy pens are dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The assessment covers dose conversion considerations, potential interaction management, and transition timing to optimise your switch from other GLP-1 medications. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout the switching process, providing professional pharmaceutical care and ongoing support.
Storage and Practical Advantages of Wegovy
When considering what's better between Mounjaro and Wegovy from a practical standpoint, storage requirements often influence patient preference and treatment adherence. Wegovy offers superior travel convenience with 6 weeks of room temperature stability below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. The medication arrives in pre-filled FlexTouch pens requiring refrigeration at 2-8°C before first use, with clear dose escalation scheduling from 0.25mg weekly through to 2.4mg maintenance. Each pen provides four weekly doses with simple subcutaneous injection into the thigh, abdomen, or upper arm. The systematic dose escalation cannot be rushed—patients must complete each 4-week phase to minimise gastrointestinal side effects and optimise tolerability. This structured approach ensures safe and effective treatment progression regardless of previous GLP-1 experience.
Why Patients Switch from Mounjaro to Wegovy: Real-World Considerations
Patients researching what's better between Mounjaro and Wegovy often switch due to practical rather than clinical reasons, including cost considerations, side effect profiles, or supply availability. Some individuals find Wegovy's single GLP-1 mechanism better tolerated than Mounjaro's dual approach, experiencing fewer gastrointestinal effects during dose escalation. The longer room temperature storage stability makes Wegovy more suitable for frequent travellers or those with irregular schedules who may forget refrigeration requirements.
Insurance coverage differences also influence switching decisions, with some patients finding better reimbursement or lower out-of-pocket costs for Wegovy compared to newer dual agonist medications. Healthcare providers may recommend switching based on individual response patterns, contraindications, or drug interaction considerations. At EverydayMeds, we facilitate these transitions by stocking both medications and providing clinical support throughout the switching process, ensuring continuity of care regardless of which option proves better for your specific circumstances.
Start Your Switch & Save Journey with EverydayMeds
Ready to discover what's better between Mounjaro and Wegovy for your weight management goals? Our clinical team stands ready to support your switching decision with professional guidance, competitive pricing starting from £79.99, and convenient bundle options for seamless treatment continuation. New customers can apply code FIRST40 at checkout, whilst returning patients benefit from code DOSE25 to access our best available pricing. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your 3-minute clinical assessment and explore your switching options. Our GPhC-registered pharmacy (#9012878) ensures safe, legal, and professional service throughout your GLP-1 medication journey. Take the first step towards optimising your weight management approach with expert support and transparent pricing that puts your health and budget first.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
